Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Ivosidenib for acute myeloid leukaemia with IDH1 mutation Ivosidenib (Tibsovo; AG-120) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2018 View  |  Download
Ivosidenib for previously treated advanced cholangiocarcinoma Ivosidenib (Tibsovo; AG-120) Cholangiocarcinoma Gastrointestinal Cancer 2022 View  |  Download
Ivosidenib with azacitidine for previously untreated acute myeloid leukaemia with an IDH1 mutation Azacitidine (Vidaza; CC-486) , Ivosidenib (Tibsovo; AG-120) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications